Salvia lachnocalyx
Salvia lachnocalyx · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Salvia lachnocalyx is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Recent investigations have focused on the dichloromethane extract derived from the plant's roots to uncover its medicinal properties. Chemical profiling of these root extracts has identified several key compounds, including 12-Hydroxysapriparaquinone, 14-deoxycoleon U, 15-Deoxyfuerstione, and 4-Dehydrosalvilimbinol. Notably, these specific constituents are being studied for their potent anticancer activities. This research highlights the importance of exploring the specialized chemical makeup of this species for future therapeutic applications.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Root
Classification
Taxonomy
Salvia lachnocalyx is a fascinating member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the order Lamiales, which helps define its evolutionary lineage. Furthermore, it is a distinct representative of the genus Salvia. Finally, this species is a proud member of the Lamiaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Salvia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Salvia lachnocalyx is a distinctive species primarily found within the Asia-Temperate geographic region. Its natural distribution is concentrated in specific areas of Western Asia, where it has adapted to local environmental conditions. Within these landscapes, the plant is particularly notable for its presence throughout the territory of Iran. Understanding these regional patterns helps researchers better grasp the ecological niche this species occupies. Consequently, its habitat remains a key focus for those studying the floral diversity of the Middle East.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Salvia lachnocalyx is a self-supporting plant that maintains its own structural integrity without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Salvia lachnocalyx contains specialized metabolites that demonstrate significant potential in the fight against cancer. Recent research has focused on specific terpenoids isolated from this plant, such as geranyl farnesol, sahandinone, and 4-dehydrosalvilimbinol. These compounds have been shown to induce apoptosis in MOLT-4 cancer cells by causing critical alterations in the cell cycle. Molecular docking and dynamics simulations suggest that these terpenoids exert their cytotoxic effects by inhibiting topoisomerase I. Consequently, these natural substances represent promising candidates for the future development of effective anticancer therapeutic agents.
Compounds
Salvia lachnocalyx is a plant known to contain several significant phytochemical constituents, particularly within its root extracts. Research has successfully isolated and identified specific diterpenoids such as 12-Hydroxysapriparaquinone and 14-deoxycoleon U from this species. Additionally, the plant is a source of 15-Deoxyfuerstione and the compound HORMINON. Beyond these, the presence of 4-Dehydrosalvilimbinol has also been documented in studies investigating its specialized metabolites. These various compounds are of great interest due to their potential roles in biological activities and therapeutic development.
Conditions
Salvia lachnocalyx demonstrates significant cytotoxic activity against both K562 human chronic myelogenous leukemia and MCF-7 human breast adenocarcinoma cell lines. The plant's terpenoids also induce apoptosis in MOLT-4 cancer cells, as evidenced by cell accumulation in the sub-G1 phase. Furthermore, these compounds are capable of causing cancer cell cycle alterations. Research also indicates that Salvia lachnocalyx influences reactive oxygen species (ROS) production during its anticancer processes. Together, these findings highlight the plant's multifaceted potential as a source for therapeutic anticancer agents.
Preparations
Salvia lachnocalyx is prepared as a dichloromethane extract specifically from its roots. This particular extraction process facilitated the isolation and identification of eight known diterpenoids from the plant. Researchers utilized this dichloromethane extract to investigate the phytochemical constituents found within the root system. Through this preparation, various compounds such as horminon and microstegiol were successfully purified. Consequently, the dichloromethane extract of the roots serves as the essential medium for studying the plant's potential anticancer properties.
Parts used
Salvia lachnocalyx possesses unique chemical properties that are primarily concentrated within its root system. Recent scientific investigations focused on dichloromethane extracts derived from these roots to identify bioactive constituents. This research successfully led to the isolation of eight distinct diterpenoids, marking the first time these specific compounds were identified from this plant part. Testing revealed that several of these root-derived compounds exhibit significant cytotoxic activity against human breast and leukemia cancer cell lines. Consequently, the chemical components found in the roots of Salvia lachnocalyx show great promise as potential candidates for future anticancer drug development.